[ad_1]
Hangzhou, China, February 20, 2024 /PRNewswire/ — Xyrox Tonbridge (2190.HK), a medical device company specializing in peripheral vascular and neurovascular interventions, proudly announces that it has recently received marketing approval from the Ministry of Health and Prevention. United Arab Emirates Applies to five advanced products. These include ZENFluxion™ Drug-Coated PTA Balloon Catheter, ZENFlow™ HP PTA Balloon Catheter, ZENFlow™ PTA Balloon Catheter, ZENFlex™ Peripheral Stent System, and ZENFLEX Pro™ Peripheral Drug-Eluting Stent System. This milestone marks Zylox-Tonbridge’s first market approval in the Gulf region and demonstrates the company’s dedication to expanding its market presence in the Gulf region. middle east Drive global business initiatives.
Zylox-Tonbridge has experienced rapid growth internationally as a provider of innovative medical solutions. With a comprehensive product portfolio focused on peripheral vascular and neurovascular interventions, the company is committed to providing pioneering products and total healthcare solutions worldwide. Its products are currently sold in more than 20 countries and regions and are widely recognized for their innovative designs and high quality.
Due to economic growth and demographic trends, middle east It has emerged as an important overseas market for Chinese medical device companies. Recognizing this opportunity, Zylox-Tonbridge consistently showcases its products at events such as the Arab Health Exhibition, solidifying its position in both local and global markets. Additionally, with the establishment of warehouses and distribution centers, Italythe company aims to better serve healthcare professionals and patients around the world. Europe, middle eastand Africa. The approval of these five of his Zylox-Tonbridge products in the UAE is expected to drive growth in the Middle East market and provide local patients with high quality, affordable and innovative medical devices. Masu.
About Xyrox Tonbridge:
Zylox-Tonbridge is one of the leading companies in the neuro and peripheral vascular interventional medical devices market. China.The company was founded in 2012 and its headquarters are in Hangzhou, China.
As a comprehensive medical device company that leverages our own R&D and manufacturing capabilities, unique technology platforms, and commercialization capabilities, we strive to provide high-quality, affordable medical devices so that everyone can use high-quality medical devices with peace of mind. We strive to provide affordable medical equipment and services to our patients. A high quality of life brought about by advanced medical technology.
For more information, please visit our official website: www.zyloxtb.com
sauce : Zylox-Tonbridge receives marketing approval for multiple products in UAE
The information provided in this article was created by Cision PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of Thailand Business News.
[ad_2]
Source link